
Julian Adin Abrams
Co-Director, T32 Multidisciplinary Training in Gastrointestinal Cancers · Columbia University Medical Center
Credentials: · · ·
History
- Present
T32 Multidisciplinary Training in Gastrointestinal Cancers · Columbia University Medical Center
- Present
Clinical Biospecimen and Research Core · Columbia University Digestive and Liver Disease Research Center
- Present
Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center
Research
Proton pump inhibitors alter the composition of the gut microbiota
Gut · 2016 · 714 citations
Cancer Cell · 2012 · 416 citations
Clinical Gastroenterology and Hepatology · 2009 · First of 7 authors · Corresponding · 282 citations

50 papers

46 papers

32 papers

25 papers

20 papers

20 papers

20 papers
- KW
18 papers
Grants
- 2024–2029
Multidisciplinary Training in Gastrointestinal Cancers
National Cancer Institute · T32
Contact PI · $896.7K · Columbia University Health Sciences
- 2022–2027
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
National Cancer Institute · R01
Contact PI · $4.1M · Columbia University Health Sciences
- 2022–2027
The Columbia University Digestive and Liver Disease Research Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $1.1M · Columbia University Health Sciences
- 2021–2026
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
National Cancer Institute · R01
Contact PI · $3.1M · Columbia University Health Sciences
Clinical trials
- 2026–2027
Ursodeoxycholic Acid in Barrett's Endotherapy
Principal investigator · Not yet recruiting
Columbia University
- 2021–2027
- 2021–2024
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Principal investigator · Completed
Columbia University
- 2018–2023
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
Principal investigator · Terminated
Columbia University



